Literature DB >> 23813748

Investigators' successful strategies for working with Institutional Review Boards.

Juliana C Cartwright1, Susan E Hickman, Christine A Nelson, Kathleen A Knafl.   

Abstract

This study was designed to identify successful strategies used by investigators for working with their Institutional Review Boards (IRBs) in conducting human subjects research. Telephone interviews were conducted with 46 investigators representing nursing, medicine, and social work. Interview transcripts were analyzed using qualitative descriptive methods. Investigators emphasized the importance of intentionally cultivating positive relationships with IRB staff and members, and managing bureaucracy. A few used evasive measures to avoid conflict with IRBs. Few successful strategies were identified for working with multiple IRBs. Although most investigators developed successful methods for working with IRBs, further research is needed on how differences in IRB culture affect human subjects protection, and on best approaches for obtaining IRB approval of multi-site studies.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  human subjects protection; human subjects research; institutional review board; qualitative; research ethics

Mesh:

Year:  2013        PMID: 23813748      PMCID: PMC3967853          DOI: 10.1002/nur.21553

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  15 in total

1.  The effects of local review on informed consent documents from a multicenter clinical trials consortium.

Authors:  William Burman; Peter Breese; Stephen Weis; Naomi Bock; John Bernardo; Andrew Vernon
Journal:  Control Clin Trials       Date:  2003-06

2.  The paradoxical problem with multiple-IRB review.

Authors:  Jerry Menikoff
Journal:  N Engl J Med       Date:  2010-10-13       Impact factor: 91.245

3.  The IRB paradox: could the protectors also encourage deceit?

Authors:  Patricia Keith-Spiegel; Gerald P Koocher
Journal:  Ethics Behav       Date:  2005

4.  Crafting Successful Relationships with the IRB.

Authors:  Jan D Carline; Patricia S O'Sullivan; Larry D Gruppen; Karen Richardson-Nassif
Journal:  Acad Med       Date:  2007-10       Impact factor: 6.893

5.  The dysregulation of human subjects research.

Authors:  Norman Fost; Robert J Levine
Journal:  JAMA       Date:  2007-11-14       Impact factor: 56.272

Review 6.  How do IRB members make decisions? A review and research agenda.

Authors:  Ivor A Pritchard
Journal:  J Empir Res Hum Res Ethics       Date:  2011-06       Impact factor: 1.742

7.  A survey of IRB process in 68 U.S. hospitals.

Authors:  Elaine Larson; Tiffany Bratts; Jack Zwanziger; Patricia Stone
Journal:  J Nurs Scholarsh       Date:  2004       Impact factor: 3.176

8.  Variation in institutional review board responses to a standard, observational, pediatric research protocol.

Authors:  Jonathan Mansbach; Uchechi Acholonu; Sunday Clark; Carlos A Camargo
Journal:  Acad Emerg Med       Date:  2007-02-20       Impact factor: 3.451

9.  U. S. Health Researchers Review their Ethics Review Boards: A Qualitative Study.

Authors:  Scott Burris; Kathryn Moss
Journal:  J Empir Res Hum Res Ethics       Date:  2006-06       Impact factor: 1.742

10.  The ethics police?: IRBs' views concerning their power.

Authors:  Robert Klitzman
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

View more
  2 in total

1.  A study to improve communication between clinicians and patients with advanced heart failure: methods and challenges behind the working to improve discussions about defibrillator management trial.

Authors:  Nathan E Goldstein; Jill Kalman; Jean S Kutner; Erik K Fromme; Mathew D Hutchinson; Hannah I Lipman; Daniel D Matlock; Keith M Swetz; Rachel Lampert; Omarys Herasme; R Sean Morrison
Journal:  J Pain Symptom Manage       Date:  2014-04-21       Impact factor: 3.612

2.  An ethics safe harbor for international genomics research?

Authors:  Edward S Dove; Bartha M Knoppers; Ma'n H Zawati
Journal:  Genome Med       Date:  2013-11-22       Impact factor: 11.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.